Skip to main content

Wingrove Theresa's Form 4 filing

ImmunoGen, Inc. (IMGN) · filed Jan 18, 2024

Accession no.
0001415889-24-001545
Filed
Jan 18, 2024
Trade date
Jan 16, 2024
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $5.56M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Wingrove TheresaCIK 0001510720Officer (SVP OF REGULATORY AFFAIRS)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 16, 2024Common StockMOption exerciseAcquired+58,900$4.83+$284,48762,326Direct
Jan 16, 2024Common StockMOption exerciseAcquired+2,667$5.75+$15,335.2564,993Direct
Jan 16, 2024Common StockMOption exerciseAcquired+126,100$5.25+$662,025191,093Direct
Jan 16, 2024Common StockSSaleDisposed−187,667$29.64−$5,562,449.883,426Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 16, 2024Common StockMOption exerciseDisposed−58,900$0.00$00Direct
Jan 16, 2024Common StockMOption exerciseDisposed−2,667$0.00$01,333Direct
Jan 16, 2024Common StockMOption exerciseDisposed−126,100$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)